Showing 1 - 10 of 11
Objective: The objective of this study was to compare costs, efficacy and cost efficacy of alternate oral antibacterial regimens for the ambulatory treatment of acute sinusitis. A public third-party perspective was adopted. Design: The analysis was based on a decision tree and considered the...
Persistent link: https://www.econbiz.de/10004990334
Persistent link: https://www.econbiz.de/10005239281
Résumé Cet article explique comment le plan de paiement anticipé des soins de santé de Bwamanda (Zaïre) a permis le maintien d'un niveau d'affiliation suffisant pour le bon fonctionnement de l'hôpital de la zone (District) de santé. Il a été rédigé à la suite d'une étude de cas...
Persistent link: https://www.econbiz.de/10008616082
Persistent link: https://www.econbiz.de/10010496333
<Emphasis Type="Bold">Background: Côte d’Ivoire, a West African country, has decided to set up a formulary as part of its universal health insurance (UHI) program. One of its goals will be to facilitate access to safe and efficacious drugs. To guarantee transparency throughout the formulary listing process, it is...</emphasis>
Persistent link: https://www.econbiz.de/10010994898
It was possible to use MCDA to simultaneously consider different decision criteria for drug reimbursement in Côte d’Ivoire; therefore, it is feasible to use MCDA to establish a formulary for low-income countries. The application of this method is a step towards transparency in policy making. </AbstractSection>...
Persistent link: https://www.econbiz.de/10011000811
Background:Background: The General Mutual Benefit Fund for Civil Servants and State Employees of Côte d'Ivoire (MUGEFCI; Mutuelle Générale des Fonctionnaires et Agents de l'État de Côte d'Ivoire) is a health mutual fund providing coverage (medical consultations, laboratory tests and...
Persistent link: https://www.econbiz.de/10011005062
Background: Côte d'Ivoire, a West African country, has decided to set up a formulary as part of its universal health insurance (UHI) program. One of its goals will be to facilitate access to safe and efficacious drugs. To guarantee transparency throughout the formulary listing process, it is...
Persistent link: https://www.econbiz.de/10011005086
Persistent link: https://www.econbiz.de/10010846086
Even with the development of the serotonin 5-HT3 receptor antagonists in recent years, postoperative nausea and vomiting (PONV) remains a significant concern for clinicians and patients. For the selection of an appropriate antiemetic strategy for PONV, economic considerations should be taken...
Persistent link: https://www.econbiz.de/10005449261